UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MAR...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under...
Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes NEW YORK, NY-(Marketwired - May 18...
Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules NEW YORK, NY - Plandaí Biotechnology's (OTCQB:...
Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales NEW YORK, NY-(Marketwired - May 04, 2017) - Plandaí...
SOURCE: Plandai Biotechnology, Inc. April 26, 2017 09:00 ET Plandai Biotechnology Gains Credibility with NutriBullet Deal NEW YORK...
NEW YORK, NY-(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a...
OMB APPROVAL OMB Number: 3235-0167 Expires: March...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.